What is Psoriatic Arthritis?

Overview of Psoriasis

Psoriasis is a condition where the immune system mistakenly attacks the skin, leading to red, scaly, and inflamed patches. These affected areas can be localized or may cover significant portions of the skin. Due to the extensive surface area and the potential for redness to be confused with a scratch or rash, psoriasis can often go unnoticed.

Connection to Psoriatic Arthritis

Psoriatic arthritis (PsA) may develop in approximately 10% to 30% of individuals with psoriasis. This type of arthritis affects both males and females equally, generally presenting symptoms between the ages of 20 and 50. Initial symptoms include swelling, pain, and inflammation in the joints, typically starting in a few isolated areas and potentially spreading to multiple joints in more severe cases.

Patterns of Psoriatic Arthritis

PsA manifests in various patterns, including:

– **Asymmetrical Pattern**: A milder form where only a few joints on opposite sides of the body are affected.
– **Symmetrical Pattern**: A more severe form where multiple joints are affected in pairs and simultaneously (e.g., both thumbs or both ankles).
– **Distal Pattern**: Involvement of joints at the ends of the fingers.
– **Spinal Pattern**: Affects the spine and sacroiliac joints, similar to spondylitis.

Symptoms and Warning Signs of PsA

PsA often begins with stiffness or mild joint pain, which may be triggered by an injury. Pain is typically more pronounced in the morning due to increased joint rigidity and may persist throughout the day. This discomfort can limit movement and is exacerbated during joint activity. Additionally, patients may experience fatigue. Notably, around 40% of individuals with PsA have a family history of the condition.

Diagnosis and Treatment of PsA

Importance of Early Treatment

Early intervention is crucial for individuals who suspect they may have PsA, as severe joint damage may become irreversible. This type of damage can occur even in mild cases and should not be dismissed as regular joint pain. Environmental factors, such as viral infections or a faulty immune response, can trigger or worsen PsA.

Treatment Options

Typical treatment for PsA includes nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids, which provide immediate relief from inflammation but are less effective for long-term disease management. To prevent joint damage, which is vital for effective treatment, a combination of disease-modifying antirheumatic drugs (DMARDs) and biologics is often recommended.

Common DMARD therapy involves methotrexate, administered orally or via injection once a week. Biologics are immunosuppressant medications designed to block proteins in the blood that contribute to pain and inflammation. In cases of PsA, a protein known as tumor necrosis factor (TNF) is elevated in the joints, and biologics aim to reduce TNF levels by inhibiting its activity.

Ongoing research at facilities such as the Canadian Centre for Clinical Trials is focused on identifying more effective treatments for PsA.

Did You Know?

PsA is characterized by intermittent phases, including periods of remission where there are no visible skin changes or joint pain, followed by flare-ups. This variability can lead to underdiagnosis, as patients may overlook transient changes in their condition.

Related Topics of Interest

– Exploring Treatment Options for Osteoarthritis
– Cellular-Based Treatment for Knee Osteoarthritis
– Grappling with Rheumatoid Arthritis
– Controlling Osteoarthritis Pain – Inefficiency of Acetaminophen/Paracetamol
– The Osteoarthritis Myth